Component
Fructose-1-phosphate formation in primary human hepatocytes
Species, exposure, manipulation and evidence limits are specified on each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
PF-06835919 inhibited labeled fructose-1-phosphate formation in primary human hepatocytes.
Experimental context and source evidence
- dose
- PF-06835919 concentration series; 10 mM labeled fructose
- duration
- 30 min pretreatment; 20 min fructose reaction
- evidence_access
- Primary full-text methods/results and metadata inspected.
- evidence_scope
- literature_reviewed; source-specific curation
- experimental_model
- Primary human hepatocytes
- exposure_scope
- Isolated fructose / investigational drug
- limitations
- Functional KHK inhibition in cells; PF-06835919 is investigational. Study sponsored/conducted by industry; pharmacological target engagement is not dietary efficacy.
- nutrient_topic
- HFCS chapter: actual formulation studies, component biochemistry and interventions are explicitly distinguished. · High-Fructose Corn Syrup / HFCS
- organism
- Primary human hepatocytes
- plain_language
- PF-06835919 inhibited labeled fructose-1-phosphate formation in primary human hepatocytes.
- primary_references
- Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction. (2021). https://pubmed.ncbi.nlm.nih.gov/33667726/ DOI: 10.1016/j.molmet.2021.101196
- route
- In vitro inhibitor pretreatment and fructose addition
- tissue
- Labeled fructose-1-phosphate production
High-Fructose Corn Syrup: mechanism of action and metabolic impact (2026-09-20) · lines 569–579
Original AI-assisted curation of twenty primary studies and official FDA composition information, with one reused canonical glucose-transport claim. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · Primary human hepatocytes · source_derived_draft · unverified_draft
## hfcs-pf-hepatocytes PF-06835919 inhibited labeled fructose-1-phosphate formation in primary human hepatocytes. Model/species: Primary human hepatocytes Tissue: Labeled fructose-1-phosphate production Exposure: PF-06835919 concentration series; 10 mM labeled fructose Route: In vitro inhibitor pretreatment and fructose addition Duration: 30 min pretreatment; 20 min fructose reaction Exposure scope: Isolated fructose / investigational drug Limits: Functional KHK inhibition in cells; PF-06835919 is investigational. Study sponsored/conducted by industry; pharmacological target engagement is not dietary efficacy. Reference: Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction. (2021). https://pubmed.ncbi.nlm.nih.gov/33667726/ DOI: 10.1016/j.molmet.2021.101196 Access: Primary full-text methods/results and metadata inspected.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.